Vera Therapeutics Ownership 2024 | Who Owns Vera Therapeutics Now?


OverviewForecastFinancialsChart

Institutional Ownership

120.00%

Insider Ownership

7.92%

Retail Ownership

-27.91%

Institutional Holders

166.00

Vera Therapeutics Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
AVORO CAPITAL ADVISORS LLC12.33%2.65%5,265,0005,265,000100.00%227,026,800Mar 31, 2024
BLACKROCK INC.7.77%0.00%3,318,964564,07020.48%143,113,727Mar 31, 2024
COMMODORE CAPITAL LP7.41%9.13%3,165,000-2,285,000-41.93%136,474,800Mar 31, 2024
FMR LLC7.31%0.01%3,123,268348,89612.58%134,675,317Mar 31, 2024
SOFINNOVA INVESTMENTS, INC.6.54%6.71%2,793,987-673,169-19.42%120,476,719Mar 31, 2024
PRICE T ROWE ASSOCIATES INC /MD/5.60%0.01%2,393,0292,393,029100.00%103,189,000Mar 31, 2024
STATE STREET CORP5.50%0.00%2,350,727169,6697.78%101,363,348Mar 31, 2024
VANGUARD GROUP INC5.03%0.00%2,148,714515,10631.53%92,652,547Mar 31, 2024
EVERSEPT PARTNERS, LP4.27%5.25%1,823,781-91,049-4.75%78,641,437Mar 31, 2024
MORGAN STANLEY3.60%0.01%1,536,790541,95054.48%66,266,386Mar 31, 2024
KYNAM CAPITAL MANAGEMENT, LP3.58%6.89%1,526,787-2,123,552-58.17%65,835,055Mar 31, 2024
HOLOCENE ADVISORS, LP2.83%0.19%1,207,3801,207,380100.00%52,062,226Mar 31, 2024
POINT72 ASSET MANAGEMENT, L.P.2.75%0.12%1,175,148190,82419.39%50,672,382Mar 31, 2024
PICTET ASSET MANAGEMENT HOLDING SA2.37%0.05%1,011,550-316,990-23.86%43,618,036Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC2.25%0.00%961,309178,59322.82%41,457,484Mar 31, 2024
WOODLINE PARTNERS LP2.22%0.38%947,097-1,560,043-62.22%40,838,823Mar 31, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.1.96%0.07%837,195837,195100.00%36,099,848Mar 31, 2024
ALTIUM CAPITAL MANAGEMENT LP1.66%12.12%710,00095,00015.45%30,615,200Mar 31, 2024
ORBIMED ADVISORS LLC1.58%0.54%675,872-842,243-55.48%29,143,601Mar 31, 2024
POLAR CAPITAL HOLDINGS PLC1.58%0.15%675,000-50,000-6.90%29,106,000Mar 31, 2024

Vera Therapeutics's largest institutional shareholder is AVORO CAPITAL ADVISORS LLC, holding 12.33% of the company's total share outstanding, currently valued at $227.03M. The top 10 institutional shareholders own together 65.37% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ALTIUM CAPITAL MANAGEMENT LP1.66%12.12%710,00095,00015.45%30,615,200Mar 31, 2024
COMMODORE CAPITAL LP7.41%9.13%3,165,000-2,285,000-41.93%136,474,800Mar 31, 2024
KYNAM CAPITAL MANAGEMENT, LP3.58%6.89%1,526,787-2,123,552-58.17%65,835,055Mar 31, 2024
SOFINNOVA INVESTMENTS, INC.6.54%6.71%2,793,987-673,169-19.42%120,476,719Mar 31, 2024
EVERSEPT PARTNERS, LP4.27%5.25%1,823,781-91,049-4.75%78,641,437Mar 31, 2024
AVORO CAPITAL ADVISORS LLC12.33%2.65%5,265,0005,265,000100.00%227,026,800Mar 31, 2024
AFFINITY ASSET ADVISORS, LLC1.10%2.51%470,000470,000100.00%20,266,400Mar 31, 2024
LOGOS GLOBAL MANAGEMENT LP1.35%2.01%575,000575,000100.00%24,794,000Mar 31, 2024
INTEGRAL HEALTH ASSET MANAGEMENT, LLC0.84%1.44%360,000360,000100.00%15,523,200Mar 31, 2024
FIRST LIGHT ASSET MANAGEMENT, LLC1.02%1.44%436,133436,133100.00%18,806,055Mar 31, 2024
CARNEGIE MELLON UNIVERSITY0.04%0.86%16,060--692,507Mar 31, 2024
FIRST TURN MANAGEMENT, LLC0.28%0.76%118,260118,260100.00%5,099,371Mar 31, 2024
SECTORAL ASSET MANAGEMENT INC0.11%0.76%44,901-79,250-63.83%1,936,131Mar 31, 2024
ARTAL GROUP S.A.1.18%0.56%506,019506,019100.00%21,819,539Mar 31, 2024
ORBIMED ADVISORS LLC1.58%0.54%675,872-842,243-55.48%29,143,601Mar 31, 2024
AVIDITY PARTNERS MANAGEMENT LP0.90%0.53%383,500383,500100.00%16,536,520Mar 31, 2024
SAMLYN CAPITAL, LLC1.51%0.47%645,501645,501100.00%27,834,003Mar 31, 2024
EAM INVESTORS, LLC0.15%0.42%62,84362,843100.00%2,709,790Mar 31, 2024
ALPHABET INC.0.56%0.41%241,264-60,316-20.00%10,403,303Mar 31, 2024
WOODLINE PARTNERS LP2.22%0.38%947,097-1,560,043-62.22%40,838,823Mar 31, 2024

The largest Vera Therapeutics shareholder by % of total assets is ALTIUM CAPITAL MANAGEMENT LP. The company owns 710.00K shares of Vera Therapeutics (VERA), representing 12.12% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
AVORO CAPITAL ADVISORS LLC12.33%2.65%5,265,0005,265,000100.00%227,026,800Mar 31, 2024
PRICE T ROWE ASSOCIATES INC /MD/5.60%0.01%2,393,0292,393,029100.00%103,189,000Mar 31, 2024
HOLOCENE ADVISORS, LP2.83%0.19%1,207,3801,207,380100.00%52,062,226Mar 31, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.1.96%0.07%837,195837,195100.00%36,099,848Mar 31, 2024
SAMLYN CAPITAL, LLC1.51%0.47%645,501645,501100.00%27,834,003Mar 31, 2024
READYSTATE ASSET MANAGEMENT LP1.39%0.36%594,091594,091100.00%25,617,204Mar 31, 2024
LOGOS GLOBAL MANAGEMENT LP1.35%2.01%575,000575,000100.00%24,794,000Mar 31, 2024
BLACKROCK INC.7.77%0.00%3,318,964564,07020.48%143,113,727Mar 31, 2024
MORGAN STANLEY3.60%0.01%1,536,790541,95054.48%66,266,386Mar 31, 2024
VANGUARD GROUP INC5.03%0.00%2,148,714515,10631.53%92,652,547Mar 31, 2024
ARTAL GROUP S.A.1.18%0.56%506,019506,019100.00%21,819,539Mar 31, 2024
MARSHALL WACE, LLP1.13%0.03%480,519480,519100.00%20,719,980Mar 31, 2024
AFFINITY ASSET ADVISORS, LLC1.10%2.51%470,000470,000100.00%20,266,400Mar 31, 2024
FIRST LIGHT ASSET MANAGEMENT, LLC1.02%1.44%436,133436,133100.00%18,806,055Mar 31, 2024
VOLORIDGE INVESTMENT MANAGEMENT, LLC1.05%0.07%446,905430,1442566.34%19,270,544Mar 31, 2024
D. E. SHAW & CO., INC.1.41%0.02%601,036390,997186.15%25,916,672Mar 31, 2024
AVIDITY PARTNERS MANAGEMENT LP0.90%0.53%383,500383,500100.00%16,536,520Mar 31, 2024
INTEGRAL HEALTH ASSET MANAGEMENT, LLC0.84%1.44%360,000360,000100.00%15,523,200Mar 31, 2024
FMR LLC7.31%0.01%3,123,268348,89612.58%134,675,317Mar 31, 2024
ROCK SPRINGS CAPITAL MANAGEMENT LP0.80%0.37%341,168341,168100.00%14,711,164Mar 31, 2024

As of Mar 31 2024, Vera Therapeutics's largest institutional buyer is AVORO CAPITAL ADVISORS LLC. The company purchased 5.26M stocks of VERA, valued at $227.03M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
COMMODORE CAPITAL LP7.41%9.13%3,165,000-2,285,000-41.93%136,474,800Mar 31, 2024
KYNAM CAPITAL MANAGEMENT, LP3.58%6.89%1,526,787-2,123,552-58.17%65,835,055Mar 31, 2024
WOODLINE PARTNERS LP2.22%0.38%947,097-1,560,043-62.22%40,838,823Mar 31, 2024
CARLYLE GROUP INC.----1,438,155-100.00%-Mar 31, 2024
ORBIMED ADVISORS LLC1.58%0.54%675,872-842,243-55.48%29,143,601Mar 31, 2024
SCHRODER INVESTMENT MANAGEMENT GROUP0.82%0.02%351,653-759,307-68.35%15,163,277Mar 31, 2024
SOFINNOVA INVESTMENTS, INC.6.54%6.71%2,793,987-673,169-19.42%120,476,719Mar 31, 2024
PICTET ASSET MANAGEMENT HOLDING SA2.37%0.05%1,011,550-316,990-23.86%43,618,036Mar 31, 2024
AXA S.A.0.64%0.04%272,078-110,613-28.90%11,732,003Mar 31, 2024
EVERSEPT PARTNERS, LP4.27%5.25%1,823,781-91,049-4.75%78,641,437Mar 31, 2024
GOLDMAN SACHS GROUP INC1.31%0.00%559,790-89,428-13.77%24,138,144Mar 31, 2024
UBS OCONNOR LLC0.06%0.09%27,566-79,406-74.23%1,188,646Mar 31, 2024
SECTORAL ASSET MANAGEMENT INC0.11%0.76%44,901-79,250-63.83%1,936,131Mar 31, 2024
BARCLAYS PLC0.10%0.00%43,568-70,179-61.70%1,879,000Mar 31, 2024
ALPHABET INC.0.56%0.41%241,264-60,316-20.00%10,403,303Mar 31, 2024
GSA CAPITAL PARTNERS LLP----52,590-100.00%-Mar 31, 2024
NUVEEN ASSET MANAGEMENT, LLC0.34%0.00%146,823-51,361-25.92%6,331,008Mar 31, 2024
POLAR CAPITAL HOLDINGS PLC1.58%0.15%675,000-50,000-6.90%29,106,000Mar 31, 2024
PLATINUM INVESTMENT MANAGEMENT LTD0.36%0.27%153,932-46,370-23.15%6,637,548Mar 31, 2024
DIMENSIONAL FUND ADVISORS LP0.04%0.00%17,732-33,190-65.18%764,604Mar 31, 2024

As of Mar 31 2024, Vera Therapeutics's biggest institutional seller is COMMODORE CAPITAL LP. The company sold -2.29M shares of VERA, valued at $136.47M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
AVORO CAPITAL ADVISORS LLC12.33%2.65%5,265,0005,265,000100.00%227,026,800Mar 31, 2024
PRICE T ROWE ASSOCIATES INC /MD/5.60%0.01%2,393,0292,393,029100.00%103,189,000Mar 31, 2024
HOLOCENE ADVISORS, LP2.83%0.19%1,207,3801,207,380100.00%52,062,226Mar 31, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.1.96%0.07%837,195837,195100.00%36,099,848Mar 31, 2024
SAMLYN CAPITAL, LLC1.51%0.47%645,501645,501100.00%27,834,003Mar 31, 2024
READYSTATE ASSET MANAGEMENT LP1.39%0.36%594,091594,091100.00%25,617,204Mar 31, 2024
LOGOS GLOBAL MANAGEMENT LP1.35%2.01%575,000575,000100.00%24,794,000Mar 31, 2024
ARTAL GROUP S.A.1.18%0.56%506,019506,019100.00%21,819,539Mar 31, 2024
MARSHALL WACE, LLP1.13%0.03%480,519480,519100.00%20,719,980Mar 31, 2024
AFFINITY ASSET ADVISORS, LLC1.10%2.51%470,000470,000100.00%20,266,400Mar 31, 2024
FIRST LIGHT ASSET MANAGEMENT, LLC1.02%1.44%436,133436,133100.00%18,806,055Mar 31, 2024
AVIDITY PARTNERS MANAGEMENT LP0.90%0.53%383,500383,500100.00%16,536,520Mar 31, 2024
INTEGRAL HEALTH ASSET MANAGEMENT, LLC0.84%1.44%360,000360,000100.00%15,523,200Mar 31, 2024
ROCK SPRINGS CAPITAL MANAGEMENT LP0.80%0.37%341,168341,168100.00%14,711,164Mar 31, 2024
LORD, ABBETT & CO. LLC0.53%0.03%225,581225,581100.00%9,727,000Mar 31, 2024
TD ASSET MANAGEMENT INC0.31%0.01%130,338130,338100.00%5,620,175Mar 31, 2024
FIRST TURN MANAGEMENT, LLC0.28%0.76%118,260118,260100.00%5,099,371Mar 31, 2024
CANDRIAM S.C.A.0.25%0.03%108,000108,000100.00%4,656,960Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.20%0.00%87,00087,000100.00%3,751,440Mar 31, 2024
JENNISON ASSOCIATES LLC0.18%0.00%74,93974,939100.00%3,231,369Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.16%0.00%67,70067,700100.00%2,919,224Mar 31, 2024
EAM INVESTORS, LLC0.15%0.42%62,84362,843100.00%2,709,790Mar 31, 2024
SEVEN EIGHT CAPITAL, LP0.15%0.28%61,96861,968100.00%2,672,060Mar 31, 2024
TWO SIGMA ADVISERS, LP0.14%0.01%60,40060,400100.00%2,604,448Mar 31, 2024
HUDSON BAY CAPITAL MANAGEMENT LP0.09%0.01%40,00040,000100.00%1,724,800Mar 31, 2024
STEMPOINT CAPITAL LP0.09%0.02%40,00040,000100.00%75,000Mar 31, 2024
CAPTRUST FINANCIAL ADVISORS0.09%0.01%37,74437,744100.00%1,627,521Mar 31, 2024
TUDOR INVESTMENT CORP ET AL0.09%0.01%37,73737,737100.00%1,627,219Mar 31, 2024
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.0.09%0.01%37,41837,418100.00%1,613,464Mar 31, 2024
MILLENNIUM MANAGEMENT LLC0.08%0.00%34,79134,791100.00%1,500,188Mar 31, 2024
NOMURA HOLDINGS INC0.08%0.00%32,90032,900100.00%1,418,648Mar 31, 2024
CAPTION MANAGEMENT, LLC0.08%0.02%32,50032,500100.00%1,401,400Mar 31, 2024
J. GOLDMAN & CO LP0.07%0.04%30,18130,181100.00%1,301,405Mar 31, 2024
J. GOLDMAN & CO LP0.06%0.04%27,00027,000100.00%1,164,240Mar 31, 2024
ARTIA GLOBAL PARTNERS LP0.06%0.21%24,29824,298100.00%1,047,730Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.05%0.00%22,54322,543100.00%972,054Mar 31, 2024
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP0.05%0.00%22,17922,179100.00%956,000Mar 31, 2024
AQR CAPITAL MANAGEMENT LLC0.05%0.00%20,43520,435100.00%881,158Mar 31, 2024
QUBE RESEARCH & TECHNOLOGIES LTD0.05%0.00%20,35620,356100.00%877,751Mar 31, 2024
UBS OCONNOR LLC0.05%0.01%20,00020,000100.00%83,000Mar 31, 2024
UBS OCONNOR LLC0.05%0.01%20,00020,000100.00%97,000Mar 31, 2024
FORA CAPITAL, LLC0.04%0.06%16,05816,058100.00%692,421Mar 31, 2024
Y-INTERCEPT (HONG KONG) LTD0.03%0.05%14,33814,338100.00%618,255Mar 31, 2024
NOMURA HOLDINGS INC0.03%0.00%13,90513,905100.00%599,584Mar 31, 2024
BAYESIAN CAPITAL MANAGEMENT, LP0.03%0.06%13,42213,422100.00%578,757Mar 31, 2024
ALLIANZ ASSET MANAGEMENT GMBH0.03%0.00%13,10013,100100.00%564,872Mar 31, 2024
ALGERT GLOBAL LLC0.03%0.02%12,42012,420100.00%536,000Mar 31, 2024
FRANKLIN RESOURCES INC0.03%0.00%12,28412,284100.00%529,686Mar 31, 2024
BELVEDERE TRADING LLC0.03%0.00%12,00012,000100.00%517,440Mar 31, 2024
TREXQUANT INVESTMENT LP0.03%0.01%11,57511,575100.00%499,114Mar 31, 2024
VICTORY CAPITAL MANAGEMENT INC0.03%0.00%11,14711,147100.00%480,659Mar 31, 2024
SEI INVESTMENTS CO0.03%0.00%11,10911,109100.00%479,018Mar 31, 2024
AMERIPRISE FINANCIAL INC0.03%0.00%10,98410,984100.00%473,630Mar 31, 2024
PROSHARE ADVISORS LLC0.03%0.00%10,88510,885100.00%469,362Mar 31, 2024
EFG ASSET MANAGEMENT (NORTH AMERICA) CORP.0.02%0.08%10,34310,343100.00%445,680Mar 31, 2024
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)0.02%0.01%10,20810,208100.00%440,169Mar 31, 2024
ARIZONA STATE RETIREMENT SYSTEM0.02%0.00%8,6578,657100.00%373,290Mar 31, 2024
E FUND MANAGEMENT CO., LTD.0.02%0.02%8,2608,260100.00%356,171Mar 31, 2024
TEACHER RETIREMENT SYSTEM OF TEXAS0.02%0.00%7,0097,009100.00%302,000Mar 31, 2024
WEXFORD CAPITAL LP0.01%0.05%6,0896,089100.00%262,558Mar 31, 2024
CAPSTONE INVESTMENT ADVISORS, LLC0.01%0.00%5,7565,756100.00%248,199Mar 31, 2024
GTS SECURITIES LLC0.01%0.00%5,6015,601100.00%241,515Mar 31, 2024
CETERA ADVISORS LLC0.01%0.00%5,4605,460100.00%235,435Mar 31, 2024
ARROWMARK COLORADO HOLDINGS LLC0.01%0.00%5,0005,000100.00%215,600Mar 31, 2024
SIMPLEX TRADING, LLC0.01%0.00%3,3293,329100.00%143,000Mar 31, 2024
BELVEDERE TRADING LLC0.01%0.00%2,5022,502100.00%107,886Mar 31, 2024
CAPTION MANAGEMENT, LLC0.01%0.00%2,2002,200100.00%94,864Mar 31, 2024
0.00%0.00%1,9881,988100.00%85,711Mar 31, 2024
BELVEDERE TRADING LLC0.00%0.00%1,5001,500100.00%64,680Mar 31, 2024
CUTLER GROUP LLC / CA0.00%0.02%1,3351,335100.00%57,000Mar 31, 2024
KBC GROUP NV0.00%0.00%1,0901,090100.00%47,000Mar 31, 2024
PACER ADVISORS, INC.0.00%0.00%810810100.00%34,927Mar 31, 2024
COMERICA BANK0.00%-4848100.00%2,070,000Mar 31, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC--77100.00%301Mar 31, 2024

Vera Therapeutics's largest new institutional shareholder by number of shares is AVORO CAPITAL ADVISORS LLC, purchased 5.26M shares, valued at $227.03M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CARLYLE GROUP INC.----1,438,155-100.00%-Mar 31, 2024
GSA CAPITAL PARTNERS LLP----52,590-100.00%-Mar 31, 2024
EXODUSPOINT CAPITAL MANAGEMENT, LP----28,005-100.00%-Mar 31, 2024
PALE FIRE CAPITAL SE----16,389-100.00%-Mar 31, 2024
BALYASNY ASSET MANAGEMENT L.P.----10,430-100.00%-Mar 31, 2024

Vera Therapeutics's largest sold out institutional shareholder by shares sold is CARLYLE GROUP INC., sold -1.44M shares, valued at -, as of undefined.

Vera Therapeutics Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
VARIABLE INSURANCE PRODUCTS FUND IV0.06%160,000--Dec 31, 2023
FIDELITY MT VERNON STREET TRUST0.04%1,263,43561,0635.08%Feb 29, 2024
FIDELITY CAPITAL TRUST0.04%465,718--Jan 31, 2024
VANGUARD VALLEY FORGE FUNDS0.04%20,452--Dec 31, 2023
FIDELITY ADVISOR SERIES VII0.02%211,854--Jan 31, 2024
PRUDENTIAL SECTOR FUNDS, INC.0.02%41,85941,859-Feb 29, 2024
Fidelity Central Investment Portfolios LLC0.01%280,000--Feb 29, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.01%5,225--Dec 31, 2023
FIDELITY SELECT PORTFOLIOS0.01%739,878220,69642.51%Feb 29, 2024
TIAA SEPARATE ACCOUNT VA 10.01%2,5361255.18%Dec 31, 2023
LORD ABBETT SECURITIES TRUST0.01%48,38348,383-Jan 31, 2024
QUANTITATIVE MASTER SERIES LLC0.01%63,1796,87412.21%Dec 31, 2023
FIDELITY COMMONWEALTH TRUST0.01%27,7278,29142.66%Feb 29, 2024
VARIABLE INSURANCE PRODUCTS FUND0.00%75,000--Dec 31, 2023
VANGUARD INDEX FUNDS0.00%1,904,838562,38741.89%Dec 31, 2023
Nushares ETF Trust0.00%29,7032,4488.98%Jan 31, 2024
ETFis Series Trust I0.00%5,5745,574-Jan 31, 2024
Fidelity Commonwealth Trust II0.00%25,85325,853-Aug 31, 2023
ALPS ETF Trust0.00%32,6041,3034.16%Feb 29, 2024
ProFunds0.00%18,6518,79489.22%Jan 31, 2024
FIDELITY CONCORD STREET TRUST0.00%414,10681,75124.60%Feb 29, 2024
VARIABLE INSURANCE PRODUCTS FUND II0.00%19,8682,86416.84%Dec 31, 2023
Calvert Variable Products, Inc.0.00%3,312--Dec 31, 2023
FIDELITY COVINGTON TRUST0.00%18,136-3,817-17.39%Feb 29, 2024
SCHWAB STRATEGIC TRUST0.00%227,84549,16927.52%Feb 29, 2024
Direxion Shares ETF Trust0.00%163,94456,84153.07%Jan 31, 2024
FIDELITY SECURITIES FUND0.00%90,426--Jan 31, 2024
INVESCO EXCHANGE-TRADED FUND TRUST0.00%70,553-147,266-67.61%Jan 31, 2024
Principal Exchange-Traded Funds0.00%8,499-699-7.60%Mar 31, 2024
Invesco Exchange-Traded Fund Trust II0.00%195,87740,22125.84%Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%16,082--Dec 31, 2023
AdvisorShares Trust0.00%1,403--Dec 29, 2023
Voya VARIABLE PORTFOLIOS INC0.00%13,762--Dec 31, 2023
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%1,693--Dec 31, 2023
Brinker Capital Destinations Trust0.00%13,54812,9272081.64%Feb 29, 2024
VANGUARD WORLD FUND0.00%51,914--Feb 29, 2024
TIAA-CREF LIFE FUNDS0.00%550--Dec 31, 2023
RBB FUND, INC.0.00%14,18214,182-Feb 29, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%11,5007006.48%Dec 31, 2023
T. Rowe Price Index Trust, Inc.0.00%1,964--Feb 29, 2024
iSHARES TRUST0.00%1,558,085--Feb 29, 2024
EQ ADVISORS TRUST0.00%93,246-2,021-2.12%Dec 31, 2023
Dimensional ETF Trust0.00%33,581--Jan 31, 2024
VANGUARD SCOTTSDALE FUNDS0.00%151,13916,72412.44%Feb 29, 2024
RYDEX SERIES FUNDS0.00%309--Dec 31, 2023
Goldman Sachs ETF Trust0.00%6,933-270-3.75%Feb 29, 2024
VANGUARD WELLINGTON FUND0.00%25,6708,47149.25%Feb 29, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%8,1503,01958.84%Dec 31, 2023
VALIC Co I0.00%12,976-52-0.40%Feb 29, 2024
PENN SERIES FUNDS INC0.00%1,200--Dec 29, 2023
SPDR SERIES TRUST0.00%1,523,786428,69139.15%Dec 31, 2023
RYDEX DYNAMIC FUNDS0.00%153--Dec 31, 2023
PROSHARES TRUST0.00%8,8784,507103.11%Feb 29, 2024
NATIONWIDE MUTUAL FUNDS0.00%3,658-155-4.07%Jan 31, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%29,297-95,300-76.49%Dec 31, 2023
NORTHERN FUNDS0.00%21,8986,66443.74%Dec 29, 2023
Pacer Funds Trust0.00%933933-Jan 31, 2024
RYDEX VARIABLE TRUST0.00%20--Dec 31, 2023
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%28,200--Dec 31, 2023
Guggenheim Active Allocation Fund0.00%76--Feb 29, 2024
MORGAN STANLEY PATHWAY FUNDS0.00%1,189--Feb 29, 2024
ADVANCED SERIES TRUST0.00%45,600--Dec 29, 2023
SUNAMERICA SERIES TRUST0.00%3,831-15-0.39%Jan 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%10,003--Jan 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%13,009-503-3.72%Dec 31, 2023
Advisors' Inner Circle Fund III0.00%882233.33%Jan 31, 2024
Columbia Funds Series Trust II0.00%2,1102,110-Feb 29, 2024
Brighthouse Funds Trust II0.00%11,588--Dec 31, 2023
Franklin Alternative Strategies Funds0.00%2,4202,420-Feb 29, 2024
AMERICAN CENTURY ETF TRUST0.00%424--Feb 29, 2024
PACIFIC SELECT FUND0.00%12,671-70-0.55%Dec 31, 2023
SPDR INDEX SHARES FUNDS0.00%452--Dec 31, 2023
Bridge Builder Trust0.00%9,964--Dec 31, 2023
MASSMUTUAL SELECT FUNDS0.00%1,073--Dec 31, 2023
WILSHIRE MUTUAL FUNDS INC0.00%307-10-3.15%Dec 31, 2023
BlackRock Variable Series Funds, Inc.0.00%4,194--Dec 31, 2023
John Hancock Funds II0.00%13,85212,252765.75%Feb 29, 2024
SEI INSTITUTIONAL INVESTMENTS TRUST0.00%16,93910,239152.82%Feb 29, 2024
T. Rowe Price Multi-Strategy Total Return Fund, Inc.0.00%4545-Jan 31, 2024

Vera Therapeutics's largest mutual fund holder by % of total assets is "VARIABLE INSURANCE PRODUCTS FUND IV", owning 160.00K shares, compromising 0.06% of its total assets.

Vera Therapeutics Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 2416674.74%
31 Dec, 239513.10%
30 Sep, 23843.70%
30 Jun, 238115.71%
31 Mar, 237020.69%
31 Dec, 22585.45%
30 Sep, 225510.00%
30 Jun, 2250-
31 Mar, 225035.14%
31 Dec, 213719.35%
30 Sep, 213147.62%
30 Jun, 2121-

As of 31 Mar 24, 166 institutions are holding Vera Therapeutics's shares, representing an increase of 74.74% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 2451,247,79024.02%
31 Dec, 2341,320,5875.30%
30 Sep, 2339,239,5882.95%
30 Jun, 2338,115,9412.12%
31 Mar, 2337,325,09474.97%
31 Dec, 2221,332,619-0.96%
30 Sep, 2221,539,8505.61%
30 Jun, 2220,394,9733.66%
31 Mar, 2219,674,56139.98%
31 Dec, 2114,054,792-4.46%
30 Sep, 2114,710,7331.36%
30 Jun, 2114,513,290-

Vera Therapeutics (VERA) has 51.25M shares outstanding as of 31 Mar 24, up 24.02% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 24120.00%1.38%
31 Dec, 2393.14%1.19%
30 Sep, 2388.64%0.87%
30 Jun, 23101.19%1.03%
31 Mar, 2399.09%1.54%
31 Dec, 2280.29%1.28%
30 Sep, 2279.14%1.40%
30 Jun, 2275.32%1.14%
31 Mar, 2281.21%1.86%
31 Dec, 2166.06%1.38%
30 Sep, 2169.14%0.36%
30 Jun, 21138.22%-

As of 31 Mar 24, Vera Therapeutics is held by 120.00% institutional shareholders, representing a 1.38% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 24121128.30%
31 Dec, 2353-1.85%
30 Sep, 23545.88%
30 Jun, 23512.00%
31 Mar, 235056.25%
31 Dec, 2232-
30 Sep, 223228.00%
30 Jun, 2225-34.21%
31 Mar, 223840.74%
31 Dec, 212717.39%
30 Sep, 21239.52%
30 Jun, 2121-

121 institutional shareholders have increased their position in VERA stock as of 31 Mar 24 compared to 53 in the previous quarter (a 128.30% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 243042.86%
31 Dec, 232140.00%
30 Sep, 2315-25.00%
30 Jun, 2320122.22%
31 Mar, 239-30.77%
31 Dec, 221344.44%
30 Sep, 229-18.18%
30 Jun, 221137.50%
31 Mar, 22860.00%
31 Dec, 21566.67%
30 Sep, 213-
30 Jun, 21--

30 institutional shareholders have reduced their position in VERA stock as of 31 Mar 24 compared to 21 in the previous quarter (a 42.86% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 2416674.74%51,247,79024.02%120.00%1.38%121128.30%3042.86%
31 Dec, 239513.10%41,320,5875.30%93.14%1.19%53-1.85%2140.00%
30 Sep, 23843.70%39,239,5882.95%88.64%0.87%545.88%15-25.00%
30 Jun, 238115.71%38,115,9412.12%101.19%1.03%512.00%20122.22%
31 Mar, 237020.69%37,325,09474.97%99.09%1.54%5056.25%9-30.77%
31 Dec, 22585.45%21,332,619-0.96%80.29%1.28%32-1344.44%
30 Sep, 225510.00%21,539,8505.61%79.14%1.40%3228.00%9-18.18%
30 Jun, 2250-20,394,9733.66%75.32%1.14%25-34.21%1137.50%
31 Mar, 225035.14%19,674,56139.98%81.21%1.86%3840.74%860.00%
31 Dec, 213719.35%14,054,792-4.46%66.06%1.38%2717.39%566.67%
30 Sep, 213147.62%14,710,7331.36%69.14%0.36%239.52%3-
30 Jun, 2121-14,513,290-138.22%-21---

Vera Therapeutics Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 17, 2024Young Joseph Rofficer SVP, FINANCE, CHIEF ACCT OFFCRS-SaleSell8,221$42.17$346.68K53,171
May 17, 2024Young Joseph Rofficer SVP, FINANCE, CHIEF ACCT OFFCRS-SaleSell1,965$42.68$83.87K51,206
May 17, 2024Young Joseph Rofficer SVP, FINANCE, CHIEF ACCT OFFCRS-SaleSell18,151$42.22$766.32K51,206
May 17, 2024Young Joseph Rofficer SVP, FINANCE, CHIEF ACCT OFFCRS-SaleSell2,500$43.03$107.57K51,206
Apr 12, 2024Young Joseph Rofficer SVP, FINANCE, CHIEF ACCT OFFCRS-SaleSell5,714$40.00$228.56K53,171
Apr 05, 2024Grant Seanofficer CHIEF FINANCIAL OFFICERS-SaleSell69,831$40.05$2.80M96,334
Apr 05, 2024Grant Seanofficer CHIEF FINANCIAL OFFICERS-SaleSell10,988$38.65$424.71K85,346

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 17, 2024Young Joseph Rofficer SVP, FINANCE, CHIEF ACCT OFFCRM-ExemptSell20,651$7.87$162.52K69,349
May 17, 2024Young Joseph Rofficer SVP, FINANCE, CHIEF ACCT OFFCRM-ExemptSell8,221$3.94$32.39K58,589
May 17, 2024Young Joseph Rofficer SVP, FINANCE, CHIEF ACCT OFFCRS-SaleSell8,221$42.17$346.68K53,171
May 17, 2024Young Joseph Rofficer SVP, FINANCE, CHIEF ACCT OFFCRS-SaleSell1,965$42.68$83.87K51,206
May 17, 2024Young Joseph Rofficer SVP, FINANCE, CHIEF ACCT OFFCRS-SaleSell18,151$42.22$766.32K51,206
May 17, 2024Young Joseph Rofficer SVP, FINANCE, CHIEF ACCT OFFCRS-SaleSell2,500$43.03$107.57K51,206
Apr 12, 2024Young Joseph Rofficer SVP, FINANCE, CHIEF ACCT OFFCRS-SaleSell5,714$40.00$228.56K53,171
Apr 05, 2024Grant Seanofficer CHIEF FINANCIAL OFFICERS-SaleSell69,831$40.05$2.80M96,334
Apr 05, 2024Grant Seanofficer CHIEF FINANCIAL OFFICERS-SaleSell10,988$38.65$424.71K85,346

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 17, 2024Young Joseph Rofficer SVP, FINANCE, CHIEF ACCT OFFCRM-ExemptBuy18,151$7.87$142.85K69,357
May 17, 2024Young Joseph Rofficer SVP, FINANCE, CHIEF ACCT OFFCRM-ExemptSell20,651$7.87$162.52K69,349
May 17, 2024Young Joseph Rofficer SVP, FINANCE, CHIEF ACCT OFFCRM-ExemptBuy8,221$3.94$32.39K61,392
May 17, 2024Young Joseph Rofficer SVP, FINANCE, CHIEF ACCT OFFCRM-ExemptSell8,221$3.94$32.39K58,589
May 17, 2024Young Joseph Rofficer SVP, FINANCE, CHIEF ACCT OFFCRM-ExemptBuy2,500$7.87$19.68K53,706
May 17, 2024Young Joseph Rofficer SVP, FINANCE, CHIEF ACCT OFFCRS-SaleSell8,221$42.17$346.68K53,171
May 17, 2024Young Joseph Rofficer SVP, FINANCE, CHIEF ACCT OFFCRS-SaleSell1,965$42.68$83.87K51,206
May 17, 2024Young Joseph Rofficer SVP, FINANCE, CHIEF ACCT OFFCRS-SaleSell18,151$42.22$766.32K51,206
May 17, 2024Young Joseph Rofficer SVP, FINANCE, CHIEF ACCT OFFCRS-SaleSell2,500$43.03$107.57K51,206
May 17, 2024SEIDENBERG BETH Cdirector-A-AwardBuy14,000$42.69$597.66K14,000
May 17, 2024Morrison Scott Wdirector-A-AwardBuy14,000$42.69$597.66K14,000
May 17, 2024MORRISSEY MICHAELdirector-A-AwardBuy14,000$42.69$597.66K14,000
May 17, 2024Katabi Mahadirector-A-AwardBuy14,000$42.69$597.66K14,000
May 17, 2024Hall Kimballdirector-A-AwardBuy14,000$42.69$597.66K14,000
May 17, 2024ENRIGHT PATRICK Gdirector-A-AwardBuy14,000$42.69$597.66K14,000
May 17, 2024Cheng Andrewdirector-A-AwardBuy14,000$42.69$597.66K14,000
Apr 12, 2024Young Joseph Rofficer SVP, FINANCE, CHIEF ACCT OFFCRS-SaleSell5,714$40.00$228.56K53,171
Apr 05, 2024Grant Seanofficer CHIEF FINANCIAL OFFICERM-ExemptBuy99,828$14.87$1.48M166,165
Apr 05, 2024Grant Seanofficer CHIEF FINANCIAL OFFICERS-SaleSell69,831$40.05$2.80M96,334
Apr 05, 2024Grant Seanofficer CHIEF FINANCIAL OFFICERS-SaleSell10,988$38.65$424.71K85,346

The last insider sell of Vera Therapeutics's stock was made by Young Joseph R on May 17 2024, selling 20,651 shares at $7.87 per share (valued at $162.52K).

Vera Therapeutics Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024112740.74%
Q1 202499100.00%
Q4 20232366.67%
Q3 20232540.00%
Q2 20239--
Q1 20233013000.00%
Q4 2022182185.71%
Q3 202282236.36%
Q2 2022146233.33%
Q1 202210--
Q4 202111100.00%
Q3 202111100.00%
Q2 20212824116.67%
Q3 2013-7-
Q2 201311100.00%
Q1 201311100.00%
Q4 2012-1-
Q2 20122--
Q2 20111--
Q3 20101--

11 total buy trades, and 27 total sell trades (buy/sell ratio of 0.41%) were made by Vera Therapeutics's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024-24-
Q1 20241714.29%
Q4 2023---
Q3 2023-3-
Q2 20232--
Q1 202324--
Q4 2022-8-
Q3 2022-14-
Q2 202243133.33%
Q1 20225--
Q4 2021---
Q3 2021---
Q2 20217--
Q3 2013---
Q2 2013---
Q1 2013---
Q4 2012---
Q2 2012---
Q2 2011---
Q3 2010---

As of Q2 2024, Insider owners conducted 0 open market buy trades and 24 open market sell trades of Vera Therapeutics's stocks.

Vera Therapeutics Peer Ownership


TickerCompany
ANEBAnebulo Pharmaceuticals, Inc.
MLYSMineralys Therapeutics, Inc.
ANABAnaptysBio, Inc.
DICEDICE Therapeutics, Inc.
VTYXVentyx Biosciences, Inc.
TYRATyra Biosciences, Inc.
TVTXTravere Therapeutics, Inc.
THRDThird Harmonic Bio, Inc.
EWTXEdgewise Therapeutics, Inc.
ACRVAcrivon Therapeutics, Inc. Common Stock
LIANLianBio
CGEMCullinan Oncology, Inc.
GLUEMonte Rosa Therapeutics, Inc.
COGTCogent Biosciences, Inc.
ETONEton Pharmaceuticals, Inc.
ALDXAldeyra Therapeutics, Inc.
CNTBConnect Biopharma Holdings Limited
TARSTarsus Pharmaceuticals, Inc.
RLYBRallybio Corporation
XLOXilio Therapeutics, Inc.
ADAGAdagene Inc.
CYTKCytokinetics, Incorporated
RAPTRAPT Therapeutics, Inc.

VERA Ownership FAQ


Vera Therapeutics is owned by institutional shareholders (120.00%), insiders (7.92%), and public (-27.91%). The largest institutional shareholder of Vera Therapeutics is AVORO CAPITAL ADVISORS LLC (12.33% of total shares) and the top mutual fund owner is VARIABLE INSURANCE PRODUCTS FUND IV (0.06% of total shares).

Vera Therapeutics's major institutional shareholders are AVORO CAPITAL ADVISORS LLC, BLACKROCK INC., COMMODORE CAPITAL LP, FMR LLC, and SOFINNOVA INVESTMENTS, INC.. The top five shareholders own together 41.37% of the company's share outstanding.

As of Mar 2024, there are 166 institutional shareholders of Vera Therapeutics.

AVORO CAPITAL ADVISORS LLC owns 5.26M shares of Vera Therapeutics, representing 12.33% of the company's total shares outstanding, valued at $227.03M (as of Mar 2024).

As of Mar 2024, BLACKROCK INC holds 3.32M shares of Vera Therapeutics (VERA), compromising 7.77% of the company, valued at $143.11M.

COMMODORE CAPITAL LP is the third largest holder of Vera Therapeutics. The company owns 3.16M of the company's shares outstanding (worth $136.47M).